NCT00332696
- Conditions
- Abdominal Neoplasms, Carcinoma, Carcinomatosis, +11 more
- Locations
-
- Novartis Investigative Site Créteil, France
Clinical trial condition
Peritoneal Neoplasms
Explore clinical trials studying Peritoneal Neoplasms. Study availability and eligibility vary by location and protocol.
54 public trials
4 recruiting studies
Peritoneal Neoplasms trial results
NCT00191646
- Conditions
- Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +20 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Phoenix, Arizona, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Little Rock, Arkansas, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Los Gatos, California, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Modesto, California, United States
NCT00517621
- Conditions
- Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +26 more
- Locations
-
- HOTEL DIEU Hospital Paris, France
NCT00063401
- Conditions
- Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +20 more
- Locations
-
- ImClone Investigational Site New York, United States
- ImClone Investigational Site Philadelphia, Pennsylvania, United States
NCT00001332
- Conditions
- Abdominal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +8 more
- Locations
-
- National Cancer Institute (NCI) Bethesda, Maryland, United States
NCT00191607
- Conditions
- Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +20 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. St Louis, Missouri, United States
- Conditions
- Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +20 more
- Locations
-
- Dept. of Gynecology, University of Marburg Marburg, Germany
NCT00074867
- Conditions
- Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +19 more
- Locations
-
- Pfizer Investigational Site Los Angeles, California, United States
- Pfizer Investigational Site Santa Monica, California, United States
- Pfizer Investigational Site Baltimore, Maryland, United States
- Pfizer Investigational Site Boston, Massachusetts, United States
NCT00103545
- Conditions
- Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +20 more
- Locations
-
- Clinic for Gynecology and Gyn. Oncology, Humboldt University Berlin, Germany
- University Clinic Carl Gustav Carus, Gynecological hospital Dresden, Germany
- Gynecologic Hospital Düsseldorf, Germany
- University Gynecologic Hospital Essen, Germany
Active, Not Recruiting
Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery
NCT04498117
- Conditions
- Abdominal Neoplasms, Adnexal Diseases, Carcinoma, +29 more
- Locations
-
- Honor Health Phoenix, Arizona, United States
- The University of Arizona Cancer Center Tucson, Arizona, United States
- John Muir Health Clinical Research Center Concord, California, United States
- Kaiser Permanente Southern California Irvine, California, United States